ACC Cardiology Hour at AHA 2018 With Dr. Valentin Fuster

Expert Roundtable on the Hottest Trials From AHA-2018

Get a deep-dive into the hottest research released during AHA 2018 with the latest installment of ACC Cardiology Hour. In this informative video discussion, Valentin Fuster, MD, PhD, MACC; Deepak L. Bhatt, MD, MPH, FACC; Anne B. Curtis, MD, FACC; and Peter Libby, MD, FACC, and Marc Ruel, MD, MPH, share their perspectives on the most significant science released during the conference. The panelists discuss the newly released ACC/AHA Guideline for the Management of Blood Cholesterol and trials such as REDUCE-IT, DECLARE-TIMI 58, CIRT, VITAL trials and more.

  • REDUCE-IT- The Primary Results of the REDUCE-IT Trial
  • AKCEA - Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients with Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial
  • FREEDOM Follow-On Study- Long-term Survival following Multivessel Revascularization in Patients with Diabetes
  • CIRT (Cardiovascular Inflammation Reduction Trial) - Low Dose Methotrexate for the Prevention of Atherosclerotic Events
  • DECLARE-TIMI 58 - The Dapagliflozin Effect on Cardiovascular Events
  • VITAL- Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease; Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
  • Cholesterol Guidelines